Tenet Healthcare Quarterly Income Statements Chart
Quarterly
|
Annual
Tenet Healthcare Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-09-30 | 2006-03-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-09-30 | 2004-06-30 | 2003-09-30 | 2003-06-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net operating revenues | 396,711,415,108,000,000 | 43,739,955,368,000,000 | 5,082,000 | 5,021,000 | 4,990,000 | 4,801,000 | 4,638,000 | 4,745,000 | 4,856,000 | 4,894,000 | 4,954,000 | 4,781,000 | 3,181,250 | 4,557,000 | 3,648,000 | 4,520,000 | 3,418,250 | 4,568,000 | 4,560,000 | 4,545,000 | 3,423,500 | 4,489,000 | 4,506,000 | 4,699,000 | 3,550,250 | 4,586,000 | 4,802,000 | 4,813,000 | 19,606,239,000 | 4,849,000 | 4,868,000 | 5,044,000 | 5,026,000 | 4,692,000 | 4,492,000 | 4,428,000 | 4,468,000 | 4,179,000 | 4,042,000 | 3,926,000 | 3,885,000 | 2,408,000 | 2,422,000 | 2,387,000 | 2,331,000 | 2,221,000 | 2,265,000 | 2,350,000 | 1,632,000 | 2,342,000 | 2,374,000 | 2,506,000 | 2,301,000 | 2,262,000 | 2,303,000 | 2,339,000 | 2,261,000 | 2,262,000 | 2,229,000 | 2,279,000 | 2,195,000 | 2,158,000 | 2,184,000 | 2,371,000 | 2,251,000 | 2,212,000 | 2,228,000 | 2,279,000 | 2,117,000 | 2,414,000 | 2,387,000 | 2,421,000 | 2,499,000 | 2,440,000 | 2,570,000 | 3,297,000 | 3,379,000 | ||
equity in earnings of unconsolidated affiliates | 35,861,000,000 | 35,659,000,000 | 54,000 | 50,000 | 65,000 | 51,000 | 54,000 | 46,000 | 77,000 | 45,000 | 54,000 | 42,000 | 5,090,000 | 44,000 | 31,000 | 28,000 | 4,344,000 | 38,000 | 42,000 | 34,000 | 4,968,000 | 33,000 | 39,000 | 25,000 | 3,870,000 | 38,000 | 28,000 | 29,000 | 130,915,000 | 31,000 | 30,000 | 24,000 | 51,000 | 28,000 | 16,000 | ||||||||||||||||||||||||||||||||||||||||||||
less: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
salaries, wages and benefits | 18,842,842,168,000,000 | 20,842,372,321,000,000 | 2,285,000 | 2,258,000 | 2,306,000 | 2,230,000 | 2,126,000 | 2,182,000 | 2,188,000 | 2,209,000 | 2,280,000 | 2,201,000 | 1,548,250 | 2,142,000 | 1,864,000 | 2,187,000 | 1,618,750 | 2,174,000 | 2,148,000 | 2,153,000 | 1,619,500 | 2,116,000 | 2,135,000 | 2,227,000 | 1,747,500 | 2,264,000 | 2,346,000 | 2,380,000 | 9,348,968,000 | 2,314,000 | 2,316,000 | 2,402,000 | 2,443,000 | 2,258,000 | 2,185,000 | 2,125,000 | 2,118,000 | 2,028,000 | 1,956,000 | 1,921,000 | 1,872,000 | 1,172,000 | 1,166,000 | 1,161,000 | 1,091,000 | 1,050,000 | 1,054,000 | 1,078,000 | 1,029,000 | 1,019,000 | 999,000 | 1,035,000 | 967,000 | 977,000 | 969,000 | 987,000 | 989,000 | 954,000 | 949,000 | 975,000 | 967,000 | 952,000 | 967,000 | 1,036,000 | 1,023,000 | 983,000 | 993,000 | 1,019,000 | 953,000 | 1,075,000 | 1,099,000 | 1,114,000 | |||||||
supplies | 609,299,908,000,000 | 654,274,928,000,000 | 891,000 | 891,000 | 860,000 | 817,000 | 811,000 | 785,000 | 838,000 | 827,000 | 859,000 | 804,000 | 539,500 | 784,000 | 611,000 | 763,000 | 563,500 | 760,000 | 753,000 | 741,000 | 562,000 | 726,000 | 748,000 | 774,000 | 571,250 | 740,000 | 780,000 | 765,000 | 3,121,649,000 | 767,000 | 773,000 | 811,000 | 817,000 | 752,000 | 707,000 | 687,000 | 688,000 | 665,000 | 649,000 | 628,000 | 626,000 | 387,000 | 387,000 | 384,000 | 388,000 | 376,000 | 389,000 | 406,000 | 391,000 | 388,000 | 399,000 | 404,000 | 394,000 | 390,000 | 395,000 | 398,000 | 394,000 | 389,000 | 395,000 | 395,000 | 388,000 | 380,000 | 392,000 | 420,000 | 406,000 | 383,000 | 399,000 | 408,000 | 386,000 | 449,000 | 446,000 | 447,000 | 457,000 | 423,000 | 437,000 | 521,000 | 525,000 | ||
other operating expenses | 9,791,691,148,000,000 | 10,081,461,154,000,000 | 1,125,000 | 1,093,000 | 1,032,000 | 1,018,000 | 1,006,000 | 942,000 | 1,029,000 | 1,051,000 | 1,054,000 | 1,072,000 | 132,800,000 | 1,058,000 | 983,000 | 1,013,000 | 143,143,000 | 1,042,000 | 1,044,000 | 1,074,000 | 134,071,000 | 1,094,000 | 1,027,000 | 1,060,000 | 96,045,000 | 1,120,000 | 1,159,000 | 1,187,000 | 4,887,314,000 | 1,231,000 | 1,213,000 | 1,242,000 | 1,230,000 | 1,151,000 | 1,081,000 | 1,093,000 | 1,048,000 | 1,032,000 | 1,035,000 | 999,000 | 991,000 | 575,000 | 567,000 | 568,000 | 543,000 | 539,000 | 534,000 | 553,000 | 519,000 | 547,000 | 528,000 | 506,000 | 468,000 | 505,000 | 498,000 | 467,000 | 479,000 | 486,000 | 472,000 | 477,000 | 475,000 | 504,000 | 508,000 | 532,000 | 522,000 | 510,000 | 529,000 | 522,000 | 513,000 | 536,000 | 554,000 | 539,000 | 534,000 | 557,000 | 610,000 | 754,000 | 753,000 | ||
adjusted ebitda | 498,447,945,000,000 | 6,303,941,024,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
reconciliation of adjusted ebitda: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | -208,000,000 | -208,000,000 | 213,000 | 217,000 | 213,000 | 209,000 | 216,000 | 203,000 | 201,000 | 209,000 | 221,000 | 224,000 | 39,662,000 | 215,000 | 206,000 | 203,000 | 39,335,000 | 205,000 | 214,000 | 208,000 | 31,227,000 | 204,000 | 194,000 | 204,000 | 27,073,000 | 219,000 | 222,000 | 221,000 | 849,368,000 | 205,000 | 215,000 | 212,000 | 208,000 | 185,000 | 197,000 | 207,000 | 240,000 | 207,000 | 209,000 | 193,000 | 191,000 | 119,000 | 121,000 | 114,000 | 116,000 | 110,000 | 104,000 | 104,000 | 105,000 | 103,000 | 104,000 | 101,000 | 101,000 | 101,000 | 97,000 | 95,000 | 95,000 | 97,000 | 98,000 | 97,000 | 96,000 | 94,000 | 95,000 | 95,000 | |||||||||||||||
impairment and restructuring charges, and acquisition-related costs | -29,000,000 | -27,000,000 | 16,000 | 21,000 | 129,000 | 24,000 | 57,000 | 16,000 | 30,000 | 15,000 | 20,000 | 20,000 | 41,500 | 57,000 | 54,000 | 55,000 | 25,250 | 46,000 | 36,000 | 19,000 | 30,750 | 46,000 | 30,000 | 47,000 | 100,750 | 329,000 | 41,000 | 33,000 | 201,919,000 | 31,000 | 22,000 | 28,000 | 52,000 | 44,000 | 193,000 | 29,000 | 63,000 | 37,000 | 32,000 | 21,000 | 58,000 | 20,000 | 11,000 | 14,000 | |||||||||||||||||||||||||||||||||||
litigation and investigation costs | -5,000,000 | -4,000,000 | 10,000 | 4,000 | 20,000 | 12,000 | 18,000 | 20,000 | 52,000 | 29,000 | 22,000 | 13,000 | 3,250 | 9,000 | 2,000 | 2,000 | 28,750 | 84,000 | 18,000 | 13,000 | 7,000 | 9,000 | 13,000 | 6,000 | 3,000 | 6,000 | 1,000 | 5,000 | 72,750 | 4,000 | 114,000 | 173,000 | 224,000 | 50,000 | 14,000 | 3,000 | 6,000 | 4,000 | 12,000 | 3,000 | 28,000 | 1,000 | 2,000 | 0 | 2,000 | 0 | 1,000 | 2,000 | 31,000 | 5,000 | 8,000 | 11,000 | 1,500 | 2,000 | 2,000 | 2,000 | 9,000 | 1,000 | 11,250 | -5,000 | 3,000 | 47,000 | 12,000 | 3,000 | |||||||||||||||
interest expense | -203,000,000 | -218,000,000 | -226,000 | -221,000 | -219,000 | -222,000 | -222,000 | -227,000 | -221,000 | -227,000 | -235,000 | -240,000 | -12,947,000 | -263,000 | -255,000 | -243,000 | -14,956,000 | -244,000 | -247,000 | -251,000 | -13,333,000 | -249,000 | -254,000 | -255,000 | -12,936,000 | -257,000 | -260,000 | -258,000 | -978,270,000 | -243,000 | -244,000 | -243,000 | -248,000 | -248,000 | -217,000 | -199,000 | -196,000 | -186,000 | -68,750 | -59,000 | -98,000 | -118,000 | -101,000 | -107,000 | -107,000 | -109,000 | -103,000 | -112,000 | -120,000 | -110,000 | -106,000 | -106,000 | -102,000 | -104,000 | |||||||||||||||||||||||||
income from early extinguishment of debt | -8,000,000 | -11,000 | -66,000 | -43,000 | -20,000 | -31,000 | -23,000 | -79,000 | -312,000 | -4,000 | -56,750 | -180,000 | -47,000 | -500 | -1,000 | -1,000 | -41,000 | -138,000 | -26,000 | -24,000 | 0 | 0 | 0 | 15,000 | 5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
other non-operating income | 29,000,000 | 25,000,000 | 6,000 | 4,000 | 6,000 | -2,000 | 7,000 | -1,000 | 10,000 | 750 | 2,000 | 1,000 | 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gains on sales, consolidation and deconsolidation of facilities | 58,000,000 | -1,000 | -106,750 | -412,000 | -15,000 | -8,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before income taxes | 587,000,000 | 3,084,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gains on sales, consolidation and deconsolidation of facilities | 2,500,000,000 | -110,000 | -35,500 | -104,000 | -23,000 | -15,000 | -150,849,000 | -147,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
grant income | 8,000 | 3,000 | 40,000 | 54,000 | 94,000 | 6,000 | 138,000 | 3,000 | 19,000 | 31,000 | 23,648,000 | -66,000 | 511,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating income | 604,000 | 603,000 | 536,000 | 596,000 | 553,000 | 648,000 | 751,000 | 1,014,000 | 586,000 | 520,000 | 350,972,000 | 271,000 | 471,000 | 327,000 | 308,792,000 | 294,000 | 388,000 | 371,000 | 313,442,000 | 320,000 | 406,000 | 517,000 | 287,367,000 | 51,000 | 310,000 | 267,000 | 1,218,053,000 | 333,000 | 267,000 | 347,000 | 315,000 | 287,000 | 164,000 | 290,000 | 337,000 | 211,000 | 207,000 | 170,000 | 167,000 | 148,000 | 202,000 | 146,000 | 211,000 | 153,000 | 180,000 | 205,000 | 149,000 | 79,000 | 163,000 | 259,000 | 165,000 | 97,000 | 171,000 | 201,000 | 91,000 | 133,000 | 138,000 | 173,000 | 93,000 | 66,000 | 63,000 | 91,000 | 28,000 | 70,000 | 58,000 | 98,000 | 21,000 | 104,000 | 69,000 | 98,000 | 18,000 | ||||||||
yoy | 9.22% | -6.94% | -28.63% | -41.22% | -5.63% | 24.62% | -99.79% | 274.17% | 24.42% | 59.02% | 13.66% | -7.82% | 21.39% | -11.86% | -1.48% | -8.13% | -4.43% | -28.24% | 9.07% | 527.45% | 30.97% | 93.63% | -76.41% | -84.68% | 16.10% | -23.05% | 386583.49% | 16.03% | 62.80% | 19.66% | -6.53% | 36.02% | -20.77% | 70.59% | 101.80% | 42.57% | 2.48% | 16.44% | -20.85% | -3.27% | 12.22% | -28.78% | 41.61% | 93.67% | 10.43% | -20.85% | -9.70% | -18.56% | -4.68% | 28.86% | 81.32% | -27.07% | 23.91% | 16.18% | -2.15% | 101.52% | 119.05% | 90.11% | 232.14% | -5.71% | 8.62% | -7.14% | 33.33% | -32.69% | 42.03% | -78.57% | 477.78% | ||||||||||||
qoq | 0.17% | 12.50% | -10.07% | 7.78% | -14.66% | -13.72% | -25.94% | 73.04% | 12.69% | -99.85% | 129409.96% | -42.46% | 44.04% | -99.89% | 104931.29% | -24.23% | 4.58% | -99.88% | 97850.63% | -21.18% | -21.47% | -99.82% | 563364.71% | -83.55% | 16.10% | -99.98% | 365681.68% | 24.72% | -23.05% | 10.16% | 9.76% | 75.00% | -43.45% | -13.95% | 59.72% | 1.93% | 21.76% | 1.80% | 12.84% | -26.73% | 38.36% | -30.81% | 37.91% | -15.00% | -12.20% | 37.58% | 88.61% | -51.53% | -37.07% | 56.97% | 70.10% | -43.27% | -14.93% | 120.88% | -31.58% | -3.62% | -20.23% | 86.02% | 40.91% | 4.76% | -30.77% | 225.00% | -60.00% | 20.69% | -40.82% | 366.67% | -79.81% | -29.59% | 444.44% | ||||||||||
operating margin % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations, before income taxes | 373,000 | 380,000 | 321,000 | 380,000 | 265,000 | 378,000 | 528,000 | 774,000 | 319,000 | 267,000 | -1,250 | -304,000 | 214,000 | 85,000 | 20,250 | -133,000 | 140,000 | 74,000 | 120,250 | 71,000 | 150,000 | 260,000 | 17,000 | 57,000 | 97,000 | 51,000 | 78,000 | 108,000 | -68,000 | 21,000 | 66,000 | 142,000 | 62,000 | -62,000 | 65,000 | 93,000 | -11,000 | 7,000 | 7,000 | 199,000 | -16,000 | 110,000 | -35,000 | -9,000 | 1,000 | 20,000 | |||||||||||||||||||||||||||||||||
income tax expense | -80,000 | -84,000 | -74,250 | -112,000 | -86,000 | -99,000 | -16,750 | -20,000 | -30,000 | -17,000 | -15,250 | -10,000 | -67,000 | -18,000 | -51,000 | -20,000 | -3,000 | -5,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations, before discontinued operations | 293,000 | 296,000 | 274,000 | 268,000 | 179,000 | 279,000 | 420,000 | 577,000 | 258,000 | 222,000 | 55,500 | -107,000 | 169,000 | 160,000 | 3,500 | -153,000 | 110,000 | 57,000 | 90,250 | 65,000 | 106,000 | 190,000 | 9,000 | 41,000 | 62,000 | 33,000 | 48,000 | 66,000 | -56,000 | 17,000 | 48,000 | 91,000 | 60,000 | 940,000 | 45,000 | 90,000 | 24,000 | 4,000 | 3,000 | 194,000 | 18,000 | 114,000 | -19,000 | -10,000 | |||||||||||||||||||||||||||||||||||
discontinued operations: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from operations | 1,000 | 1,000 | -1,000 | 1,000 | -1,000 | 3,250 | 1,000 | 2,000 | 10,000 | 750 | 2,000 | 1,000 | -250 | -1,000 | 2,000 | 2,000 | 6,000 | 1,750 | 4,000 | 1,000 | 1,000 | -5,000 | -2,000 | -3,000 | -15,000 | 15,000 | -4,000 | -5,000 | 5,000 | 4,000 | -2,000 | -11,000 | 2,000 | 25,000 | -29,000 | 6,000 | -9,000 | ||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations | 1,000 | 1,000 | -1,000 | 1,000 | -1,000 | 2,750 | 1,000 | 2,000 | 8,000 | 750 | 2,000 | 1,000 | 3,000 | 1,000 | 1,000 | -2,000 | 15,000 | -9,000 | 22,000 | 0 | -10,000 | 5,000 | 5,000 | -5,000 | -17,000 | -11,000 | -23,000 | -10,000 | 4,000 | -21,000 | 53,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
net income | 293,000 | 296,000 | 274,000 | 268,000 | 179,000 | 280,000 | 419,000 | 578,000 | 257,000 | 222,000 | 333,709,000 | -106,000 | 169,000 | 159,000 | 289,424,000 | -152,000 | 112,000 | 65,000 | 296,901,000 | 65,000 | 108,000 | 191,000 | 268,036,000 | -289,000 | 32,000 | 36,000 | 38,250 | 80,000 | 39,000 | 34,000 | 2,000 | 28,000 | -28,000 | 76,000 | 18,000 | 36,000 | 54,000 | 32,000 | 67,000 | -66,000 | 15,000 | 63,000 | 82,000 | 82,000 | 940,000 | 35,000 | 95,000 | 29,000 | -1,000 | -14,000 | 183,000 | -33,000 | 104,000 | -15,000 | -31,000 | -75,000 | -59,000 | -30,000 | 75,000 | -89,000 | 70,000 | -408,000 | -21,000 | -3,000 | -308,000 | -195,000 | |||||||||||||
yoy | 63.69% | 5.71% | -34.61% | -53.63% | -30.35% | 26.13% | -99.87% | -645.28% | 52.07% | 39.62% | 15.30% | -30.26% | 50.89% | 144.62% | -2.52% | -333.85% | 3.70% | -65.97% | 10.77% | -122.49% | 237.50% | 430.56% | 700647.71% | -461.25% | -17.95% | 5.88% | 1812.50% | 185.71% | -239.29% | -55.26% | 55.56% | -50.00% | 12.50% | -181.82% | 113.33% | -18.29% | -180.49% | -98.40% | 80.00% | -13.68% | 182.76% | -94100.00% | -350.00% | -48.09% | -187.88% | -100.96% | -6.67% | -690.32% | -56.00% | -276.27% | -50.00% | -141.33% | -15.73% | -184.29% | -92.65% | -457.14% | 2866.67% | -93.18% | -98.46% | ||||||||||||||||||||
qoq | -1.01% | 8.03% | 2.24% | 49.72% | -36.07% | -33.17% | -27.51% | 124.90% | 15.77% | -99.93% | -314919.81% | -162.72% | 6.29% | -99.95% | -190510.53% | -235.71% | 72.31% | -99.98% | 456670.77% | -39.81% | -43.46% | -99.93% | -92846.02% | -1003.13% | -11.11% | -5.88% | -52.19% | 105.13% | 14.71% | 1600.00% | -92.86% | -200.00% | -136.84% | 68.75% | -201.52% | -540.00% | -76.19% | -23.17% | 0.00% | -91.28% | 2585.71% | -63.16% | 227.59% | -3000.00% | -92.86% | -107.65% | -654.55% | -131.73% | -793.33% | -51.61% | -58.67% | 27.12% | 96.67% | -140.00% | -184.27% | -227.14% | -117.16% | 1842.86% | 600.00% | 57.95% | |||||||||||||||||||
net income margin % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: net income available to noncontrolling interests | 170,000 | 153,000 | 172,000 | 137,000 | 141,000 | 140,000 | 170,000 | 129,000 | 138,000 | 125,000 | 59,250 | 90,000 | 81,000 | 66,000 | 64,750 | 80,000 | 95,000 | 84,000 | 62,000 | 74,000 | 82,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income available to tenet healthcare corporation common shareholders | 123,000 | 143,000 | 102,000 | 131,000 | 38,000 | 140,000 | 119,000 | 97,000 | 88,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amounts available to tenet healthcare corporation common shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations, net of tax | 123,000 | 143,000 | 102,000 | 131,000 | 38,000 | 139,000 | 250,000 | 448,000 | 120,000 | 97,000 | -3,750 | -197,000 | 88,000 | 94,000 | -61,250 | -233,000 | 15,000 | -27,000 | 28,250 | -9,000 | 24,000 | 98,000 | -10,000 | -17,000 | 33,000 | -53,000 | -86,000 | 56,000 | 30,000 | 42,000 | 57,000 | -66,000 | 8,000 | 40,000 | 82,000 | 52,000 | 932,000 | 35,000 | 83,000 | 15,000 | 2,000 | 2,000 | 189,000 | ||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of tax | 1,000 | 1,000 | -1,000 | 1,000 | -1,000 | 2,750 | 1,000 | 2,000 | 8,000 | 750 | 2,000 | 1,000 | 3,000 | 10,000 | 1,000 | 1,000 | -2,000 | 15,000 | -9,000 | 22,000 | 0 | -10,000 | 5,000 | 6,000 | -5,000 | -17,000 | -11,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share available to tenet healthcare corporation common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
continuing operations | 1.21 | 1.4 | 0.97 | 1.21 | 0.35 | 1.29 | 2.33 | 4.18 | 1.12 | 0.91 | -0.035 | -1.87 | 0.84 | 0.9 | -0.593 | -2.25 | 0.15 | -0.26 | 0.278 | -0.09 | 0.23 | 0.97 | -1.18 | -3.63 | -0.56 | -0.52 | -0.273 | -0.09 | -0.44 | -0.56 | -1.01 | -0.28 | -0.6 | 0.47 | 64,000.27 | 0.1 | -0.11 | -0.28 | 10,000 | 8,000 | 7,000 | -0.83 | 12,998.75 | 0.29 | 0.1 | 0.14 | -0.14 | 0.02 | 0.08 | 0.17 | 0.11 | 1.92 | 0.07 | 0.17 | 0.03 | 0.01 | 0.4 | -0.02 | 0.24 | -0.04 | -0.02 | -80.1 | -70 | -60 | 200 | -60 | 30 | -820 | 40 | -500 | -280 | ||||||||
discontinued operations | 0.01 | 0.01 | -0.01 | 0.01 | -0.01 | 0.028 | 0.01 | 0.02 | 0.08 | 0.008 | 0.02 | 0.01 | -0.003 | -0.01 | 0.01 | -0.01 | -0.013 | 0.01 | -0.02 | -0.04 | 0.03 | -0.01 | -0.01 | 0.01 | -0.058 | -0.01 | 0.03 | 0.09 | 0 | 0.003 | 0 | 0.03 | -0.02 | 0.04 | 0 | -0.02 | 0.01 | 0.02 | -0.01 | -0.04 | -0.02 | -0.05 | -0.02 | 0.01 | -0.04 | 120 | |||||||||||||||||||||||||||||||||
diluted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares and dilutive securities outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 101,639 | 101,766 | 102,289 | 106,929 | 107,923 | 107,790 | 107,483 | 106,833 | 107,050 | 106,822 | 106,309 | 105,263 | 104,794 | 104,353 | 103,558 | 103,198 | 102,788 | 102,402 | 102,147 | 101,392 | 100,812 | 100,612 | 100,000 | 99,523 | 99,341 | 98,768 | 99,167 | 99,537 | 99,244 | 98,699 | 97,801 | 98,036 | 97,677 | 97,161 | 101,648 | 100,894 | 103,010 | 104,103 | 104,200 | 104,244 | 415,011 | 411,373 | 468,726 | 468,753 | 486,794 | 486,902 | 484,321 | 485,210 | 484,610 | 481,917 | 480,240 | 481,008 | 480,447 | 478,372 | 476,349 | 476,898 | 476,308 | 475,066 | 473,405 | 473,984,000 | 473,212,000 | 472,136,000 | 471,227,000 | 470,069,000 | 469,179,000 | 468,758,000 | 468,047,000 | 466,646,000 | 465,922,000 | 463,629,000 | 465,110,000 | ||||||||
diluted | 104,800 | 104,778 | 106,006 | 110,516 | 109,888 | 108,750 | 112,020 | 108,571 | 108,761 | 108,569 | 108,065 | 105,263 | 105,578 | 105,733 | 103,558 | 104,629 | 102,788 | 102,402 | 104,177 | 102,656 | 100,812 | 100,612 | 100,000 | 99,523 | 99,341 | 98,768 | 99,167 | 99,537 | 99,244 | 100,872 | 100,287 | 100,926 | 97,677 | 97,161 | 101,648 | 103,098 | 103,010 | 104,103 | 108,926 | 107,311 | 427,708 | 484,873 | 485,181 | 483,632 | 503,748 | 565,181 | 560,631 | 559,850 | 502,549 | 559,228 | 507,277 | 498,084 | 488,244 | 479,512 | 478,606 | 480,789 | 476,308 | 475,066 | 473,405 | 473,984,000 | 473,212,000 | 474,326,000 | 471,227,000 | 470,745,000 | 469,179,000 | 468,758,000 | 468,947,000 | 466,646,000 | 465,922,000 | 463,629,000 | 465,110,000 | ||||||||
net incomees (gains) on sales, consolidation and deconsolidation of facilities | -13,000 | -1,000 | -1,000 | -1,000 | -2,000 | 750 | 1,000 | 1,000 | 1,000 | -27,750 | 7,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other non-operating expense | -2,000 | -750 | -3,000 | -1,000 | -500 | -1,000 | -1,000 | -3,500 | -4,000 | -5,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amounts available (attributable) to tenet healthcare corporation common shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share available (attributable) to tenet healthcare corporation common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net incomees on sales, consolidation and deconsolidation of facilities | 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax benefit | -108,000 | -197,000 | -61,000 | -45,000 | 56,750 | 197,000 | -45,000 | 75,000 | -30,000 | -6,000 | -44,000 | -70,000 | 26,250 | 60,000 | 12,000 | 33,000 | 16,000 | 1,000 | -11,000 | 27,000 | -16,000 | -60,000 | 18,000 | 9,000 | 1,000 | 8,000 | 5,000 | 20,000 | 53,000 | 1,000 | 29,000 | 0 | 106,000 | -4,000 | 18,000 | 6,000 | -2,000 | 1,002,000 | 35,000 | -3,000 | -4,000 | 6,000 | 4,000 | 16,000 | -1,000 | -20,000 | 4,000 | 92,000 | 39,000 | 18,000 | 17,000 | 16,000 | 110,000 | 136,000 | 69,000 | ||||||||||||||||||||||||
net income available (loss attributable) to tenet healthcare corporation common shareholders | 249,000 | 449,000 | 93,000 | -58,500 | -232,000 | 17,000 | -19,000 | 29,000 | -9,000 | 26,000 | 99,000 | -59,000 | -97,000 | -29,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to tenet healthcare corporation common shareholders | -3,750 | -196,000 | -118,750 | -367,000 | -55,000 | -53,000 | -28,250 | -46,000 | -61,000 | 47,000 | 61,000 | 9,000 | -26,000 | -32,000 | -24,000 | 28,000 | -50,000 | -88,000 | 49,000 | 40,000 | -6,000 | 58,000 | -76,000 | 6,000 | 55,000 | 73,000 | 74,000 | 932,000 | 25,000 | 88,000 | 21,000 | -3,000 | |||||||||||||||||||||||||||||||||||||||||||||||
electronic health record incentives | -250 | -1,000 | -250 | -1,000 | -2,000 | -1,000 | -6,000 | -31,977,000 | -21,000 | -26,000 | -33,000 | -32,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net operating revenues: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net operating revenues before benefit from doubtful accounts | 3,827,500 | 4,941,000 | 5,173,000 | 5,196,000 | 21,054,144,000 | 5,216,000 | 5,220,000 | 5,420,000 | 5,417,000 | 5,063,000 | 4,844,000 | 4,791,000 | 4,824,000 | 4,428,000 | 4,362,000 | 4,306,000 | 4,233,000 | 2,618,000 | 2,629,000 | 2,594,000 | 2,531,000 | 2,427,000 | 2,455,000 | 2,543,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: benefit from doubtful accounts | 277,250 | 355,000 | 371,000 | 383,000 | 1,447,905,000 | 367,000 | 352,000 | 376,000 | 391,000 | 371,000 | 352,000 | 363,000 | 356,000 | 249,000 | 320,000 | 380,000 | 348,000 | 210,000 | 207,000 | 207,000 | 200,000 | 206,000 | 190,000 | 193,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: net income attributable to noncontrolling interests | 92,000 | 63,500 | 78,000 | 87,000 | 89,000 | 66,500 | 88,000 | 85,000 | 93,000 | 99,000 | 57,000 | 33,000 | 29,000 | 11,000 | 9,000 | 19,000 | 16,000 | 5,000 | 3,000 | 4,000 | 3,000 | 2,000 | 3,000 | 2,000 | 2,000 | 4,000 | 1,000 | 2,000 | 2,000 | 1,000 | 5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
net income from continuing operations, before income taxes | -81,250 | -348,000 | 19,000 | 4,000 | 54,750 | 89,000 | 25,000 | 105,000 | 67,000 | 40,000 | -54,000 | 91,000 | 141,000 | 1,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from continuing operations, before discontinued operations | -55,000 | -288,000 | 31,000 | 37,000 | 39,500 | 79,000 | 41,000 | 38,000 | -1,000 | 29,000 | -27,000 | 75,000 | 81,000 | 19,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from discontinued operations | -250 | -1,000 | 1,000 | 1,000 | 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amounts attributable to tenet healthcare corporation common shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from continuing operations, net of tax | -118,500 | -366,000 | -56,000 | -52,000 | -27,000 | -44,000 | -55,000 | -100,000 | -28,000 | -60,000 | 46,000 | 61,000 | 10,000 | -27,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from discontinued operations, net of tax | -250 | -1,000 | 1,000 | 1,000 | 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per share attributable to tenet healthcare corporation common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment earnings | 7,998,000 | 2,000 | 1,000 | 1,000 | 0 | 0 | 1,000 | 0 | -1,000 | 1,000 | 0 | 1,000 | 1,000 | 1,000 | 1,000 | 3,000 | 1,000 | 1,000 | -250 | 2,000 | -5,000 | 2,000 | 1,000 | 12,000 | 4,000 | 5,000 | 11,000 | 10,000 | 15,000 | 11,000 | 15,000 | 17,000 | 17,000 | 15,000 | 9,000 | 6,000 | 3,000 | 3,000 | 4,000 | ||||||||||||||||||||||||||||||||||||||||
net income per share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share attributable to tenet healthcare corporation common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets and goodwill, and restructuring charges | 0 | 0 | 7,000 | 6,000 | 3,000 | 3,000 | 9,000 | 8,000 | 2,000 | 8,000 | -2,000 | 3,000 | -2,000 | 3,250 | 7,000 | 1,000 | 5,000 | 1,000 | 1,000 | 2,000 | 1,000 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gains on sales of facilities | 0 | 0 | 2,000 | 1,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: preferred stock dividends | 0 | 0 | 0 | 1,000 | 4,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
discontinued operations | 0.01 | 0.01 | -0.01 | 0.01 | -0.01 | 0.028 | 0.01 | 0.02 | 0.08 | 0.008 | 0.02 | 0.01 | -0.003 | -0.01 | 0.01 | -0.01 | -0.013 | 0.01 | -0.02 | -0.04 | 0.03 | -0.01 | -0.01 | 0.01 | -0.058 | -0.01 | 0.03 | 0.09 | 0 | 0.003 | 0 | 0.03 | -0.02 | 0.04 | 0 | -0.02 | 0.01 | 0.02 | -0.01 | -0.04 | -0.02 | -0.05 | -0.02 | 0.01 | -0.04 | 120 | |||||||||||||||||||||||||||||||||
earnings per share attributable to tenet healthcare corporation common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share attributable to tenet healthcare corporation common shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from doubtful accounts | 184,000 | 193,000 | 171,000 | 182,000 | 191,000 | 187,000 | 173,000 | 189,000 | 181,000 | 193,000 | 167,000 | 156,000 | 166,000 | 166,000 | 154,000 | 149,000 | 134,000 | 159,000 | 151,000 | 141,000 | 157,000 | 138,000 | 206,000 | 153,000 | 158,000 | 253,000 | 499,000 | 522,000 | 288,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
gain from early extinguishment of debt | -2,000 | -55,000 | 0 | -16,000 | -21,000 | 134,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain on sales of investments | 0 | 0 | 15,000 | 35,000 | 140,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net incomees on sales of facilities | 0 | 0 | -2,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
litigation and investigation costs (benefit), net of insurance recoveries | 3,250 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
litigation settlements, net of insurance recoveries | 39,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to tenet healthcare corporation shareholders | -15,000 | 178,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amounts attributable to tenet healthcare corporation shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share attributable to tenet healthcare corporation shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share attributable to tenet healthcare corporation shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
minority interests | -3,000 | -2,000 | -1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain on sales of facilities | 1,250 | -3,000 | 8,000 | 2,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation | 86,000 | 85,000 | 83,000 | 81,000 | 81,000 | 77,000 | 83,000 | 95,000 | 86,000 | 90,000 | 93,000 | 107,000 | 113,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization | 9,000 | 8,000 | 8,000 | 8,000 | 8,000 | 6,000 | 7,000 | 10,000 | 6,000 | 6,000 | 6,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income on sales of facilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries | 36,000 | 13,000 | 10,000 | 1,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
hurricane insurance recoveries, net of costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gains on sales of investments | 2,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations, before discontinued operations and cumulative effect of change in accounting principle | 9,250 | 93,000 | 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before cumulative effect of change in accounting principle | 75,000 | 68,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cumulative effect of change in accounting principle, net of tax | 2,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted earnings per common share and common equivalent share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
costs of litigation and investigations | 7,000 | 16,000 | 28,000 | 11,000 | 8,000 | 10,000 | 9,000 | 253,000 | 68,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from operations of asset group | 13,000 | 7,000 | 11,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain on sales of asset group | 3,000 | 22,000 | 4,000 | 31,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per common share and common equivalent share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets and restructuring charges | 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from hurricanes and related costs | 5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
insurance recovery | 45,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gains on sales of asset group | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per common share and common equivalent share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
discontinued operations | 0.01 | 0.01 | -0.01 | 0.01 | -0.01 | 0.028 | 0.01 | 0.02 | 0.08 | 0.008 | 0.02 | 0.01 | -0.003 | -0.01 | 0.01 | -0.01 | -0.013 | 0.01 | -0.02 | -0.04 | 0.03 | -0.01 | -0.01 | 0.01 | -0.058 | -0.01 | 0.03 | 0.09 | 0 | 0.003 | 0 | 0.03 | -0.02 | 0.04 | 0 | -0.02 | 0.01 | 0.02 | -0.01 | -0.04 | -0.02 | -0.05 | -0.02 | 0.01 | -0.04 | 120 | |||||||||||||||||||||||||||||||||
diluted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment and restructuring charges | 205,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from hurricane and related costs | 40,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain on sales of long-term investments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations before income taxes | 3,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations | 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per common share and common equivalent share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
salaries and benefits | 1,124,000 | 1,078,000 | 1,131,000 | 1,420,000 | 1,474,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restructuring charges | 9,000 | 2,000 | 22,000 | 8,000 | 77,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets and goodwill | 21,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain on sale of subsidiary common stock and long-term investments | 6,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of investment securities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per common share and common equivalent share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
goodwill amortization | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other amortization | 5,000 | 7,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of goodwill and long-lived assets | 1,000 | 198,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of subsidiary common stock | 9,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment charges | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per common share and common equivalent share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic |
We provide you with 20 years income statements for Tenet Healthcare stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Tenet Healthcare stock. Explore the full financial landscape of Tenet Healthcare stock with our expertly curated income statements.
The information provided in this report about Tenet Healthcare stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.